BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 318798)

  • 1. Quality control of small-volume sterile products.
    Rupp CA; Kikugawa CA; Kotabe SE; Barriere SL; Bowman WD
    Am J Hosp Pharm; 1977 Jan; 34(1):47-9. PubMed ID: 318798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro analysis of microbial transmission during EUS-guided FNA and the utility of sterilization agents.
    Sing J; Erickson R; Fader R
    Gastrointest Endosc; 2006 Nov; 64(5):774-9. PubMed ID: 17055873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiologic quality assurance for intravenous admixtures in a small hospital.
    Doss HL; James JD; Killough DM; Snodgrass GL
    Am J Hosp Pharm; 1982 May; 39(5):832-5. PubMed ID: 6805321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial contamination potential of sterile disposable plastic syringes.
    Huey WY; Newton DW; Augustine SC; Vejraska BD; Mitrano FP
    Am J Hosp Pharm; 1985 Jan; 42(1):102-5. PubMed ID: 3918439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal sampling time after preparation of platelet concentrates for detection of bacterial contamination by quantitative real-time polymerase chain reaction.
    Mohammadi T; Pietersz RN; Scholtalbers LA; Vandenbroucke-Grauls CM; Savelkoul PH; Reesink HW
    Vox Sang; 2005 Nov; 89(4):208-14. PubMed ID: 16262753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterility and use patterns of multiple-dose vials.
    Bawden JC; Jacobson JA; Jackson JC; Anderson RK; Burke JP
    Am J Hosp Pharm; 1982 Feb; 39(2):294-7. PubMed ID: 6800255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of Escherichia coli O157:H7 during storage or drying of apple slices pretreated with acidic solutions.
    Derrickson-Tharrington E; Kendall PA; Sofos JN
    Int J Food Microbiol; 2005 Mar; 99(1):79-89. PubMed ID: 15718031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a device for monitoring sterility of injectable fluids.
    Mayhall CG; Pierpaoli PG; Hall GO; Thomas RB
    Am J Hosp Pharm; 1981 Aug; 38(8):1148-50. PubMed ID: 6791498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calfactant sterility in multiple doses from single-use vials.
    Reiter PD; Sims C; Harmes L; Paisley J; Rosenberg AA; Valuck RJ
    Ann Pharmacother; 2003 Sep; 37(9):1219-23. PubMed ID: 12921502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.
    Khuu HM; Stock F; McGann M; Carter CS; Atkins JW; Murray PR; Read EJ
    Cytotherapy; 2004; 6(3):183-95. PubMed ID: 15203975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-house validation of the BACTEC 9240 blood culture system for detection of bacterial contamination in platelet concentrates.
    Dunne WM; Case LK; Isgriggs L; Lublin DM
    Transfusion; 2005 Jul; 45(7):1138-42. PubMed ID: 15987359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basics of sterile compounding: bubble point testing.
    Thoma L
    Int J Pharm Compd; 2014; 18(1):54-7. PubMed ID: 24881342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hygienic precautions and microbiological quality control during the manufacturing of sterile drugs].
    Züge R
    Zentralbl Bakteriol Mikrobiol Hyg B; 1982 May; 176(2-3):134-41. PubMed ID: 7124163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of proficiency testing for detection of bacterial contamination of platelet products.
    Easley S; Yomtovian RA; Sullivan P; Jacobs MR
    Transfusion; 2007 Feb; 47(2):251-5. PubMed ID: 17302771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tests of the microbiologic barrier in sterile packaging].
    Jakimiak B; Röhm-Rodowald E
    Rocz Panstw Zakl Hig; 2002; 53(2):197-202. PubMed ID: 12235676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of three methods for detecting bacterial contamination in intravenous solutions.
    Hoffman KH; Smith FM; Godwin HN; Hogan LC; Furtado D
    Am J Hosp Pharm; 1982 Aug; 39(8):1299-302. PubMed ID: 6751078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of refrigeration on bactericidal activity of four preserved multiple-dose injectable drug products.
    Lehmann CR
    Am J Hosp Pharm; 1977 Nov; 34(11):1196-1200. PubMed ID: 930936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.